About 95% of the SMA-affected patients are caused by the homozygous deletion of the survival of motor neuron 1 (SMN1) gene, resulting in deficiency of SMN protein (Lefebvre et al., 1995; Lefebvre et al., 1997). Here, SMN2 is linked to proximal spinal muscular atrophy.